Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’ Press Release Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’ PRINCETON, NJ – Oct. 6, 2016 – Certara announces that Kelley Kendle, president of Synchrogenix,…CertaraOctober 6, 2016
Certara Enhances SYBYL-X Drug Design and Discovery Software Suite Press Release Certara Enhances SYBYL-X Drug Design and Discovery Software Suite SYBYL-X 2.1 offers improved job control and increased QSAR accessibility ST. LOUIS, MO – Aug.…CertaraAugust 6, 2013
Pfizer Deploys Certara’s D360 for Scientific Data Access and Analysis Press Release Pfizer Deploys Certara’s D360 for Scientific Data Access and Analysis Bio-IT World News Bulletin describes how Pfizer has adopted D360 as Pfizer’s core research platform. …CertaraJuly 29, 2013